Health Care & Hospital Law
Jun. 8, 2016
Genentech, partner to pay $67M to resolve False Claims Act case
Northern District U.S. Attorney Brian J. Stretch announced Monday that Genentech Inc. and another company will pay $67 million to settle a False Claims Act lawsuit in which the companies were accused of lying about the effectiveness of cancer drug Tarceva.
Daily Journal Staff Writer
Northern District U.S. Attorney Brian J. Stretch announced Monday that Genentech Inc. and another company will pay $67 million to settle a False Claims Act lawsuit in which the companies were accused of lying about the effectiveness of cancer drug Tarceva.
Genentech, which is headquartered in South San Francisco and owned by Swiss biotechnology and health-care giant F. Ho...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In